How society's understanding of addiction has evolved over two centuries — from moral condemnation and asylum confinement to the modern disease model and evidence-based treatment.
The history of addiction treatment is, in many ways, a history of how societies have understood human suffering and human agency. For most of recorded history, people who could not control their use of alcohol or other substances were seen primarily through a moral lens: they were weak, sinful, or lacking in character. Treatment, to the extent it existed at all, was largely a matter of punishment, confinement, or religious conversion. The shift toward a medical understanding of addiction — a shift that is still incomplete and still contested — is one of the most significant developments in the history of medicine and public health.
Alcohol has been part of human culture for at least ten thousand years, and concern about its misuse is nearly as old. Ancient Egyptian texts warn against excessive drinking. The Hebrew Bible contains numerous passages condemning drunkenness. Greek and Roman writers described what we would now recognize as alcohol use disorder in terms that combined moral condemnation with something approaching clinical observation.
The dominant framework across most of human history was moral: excessive drinking was a sin, a vice, or a failure of will. This framework was not entirely without insight — it correctly identified that behavior change was central to recovery — but it was profoundly unhelpful in practice, because it placed the entire burden of change on the individual's moral resources while ignoring the physiological and psychological dimensions of addiction that make those resources insufficient.
The nineteenth century saw the first organized social response to alcohol misuse in the form of the temperance movement. Beginning in the United States and Britain in the 1820s and 1830s, temperance advocates argued that alcohol itself — not just excessive drinking — was the problem, and that the solution was abstinence. The movement was deeply intertwined with Protestant Christianity and with the social reform movements of the era, including abolitionism and women's suffrage.
The temperance movement produced the first systematic attempts to understand and treat alcoholism as something other than a simple moral failing. Benjamin Rush, one of the signers of the Declaration of Independence and a prominent physician, published a treatise in 1784 arguing that habitual drunkenness was a disease of the will — one of the first medical framings of what we now call alcohol use disorder. Rush's ideas were ahead of their time and had limited immediate impact, but they planted a seed that would eventually grow into the modern disease model.
The nineteenth century also saw the development of the first institutional responses to alcoholism. "Inebriate asylums" — residential facilities specifically for the treatment of habitual drunkards — began to appear in the United States and Britain in the 1840s and 1850s. These facilities varied enormously in their approaches, ranging from humane therapeutic communities to essentially punitive institutions. Most relied on a combination of enforced abstinence, moral instruction, and physical labor. Their long-term success rates were poor, but they represented the first acknowledgment that alcoholism required specialized treatment rather than simply punishment or moral exhortation.
The late nineteenth and early twentieth centuries were characterized by a proliferation of patent medicine "cures" for alcoholism and drug addiction. These products — typically containing alcohol, opiates, cocaine, or other psychoactive substances — were marketed with extravagant claims and no scientific basis. The Keeley Cure, developed by Dr. Leslie Keeley in the 1880s, claimed to cure alcoholism with injections of "bichloride of gold" (which contained no gold and whose active ingredients were never disclosed). Despite its lack of scientific credibility, the Keeley Cure attracted hundreds of thousands of patients and spawned a network of treatment institutes across the United States.
The opiate epidemic of the late nineteenth century — driven in part by the widespread prescription of morphine and the introduction of heroin as a supposedly non-addictive substitute — also produced the first serious medical engagement with drug addiction. Physicians began to recognize that their patients were becoming physically dependent on the drugs they prescribed, and that this dependence had physiological as well as psychological dimensions. This recognition laid the groundwork for the eventual development of the disease model of addiction.
The United States' experiment with Prohibition (1920–1933) was the temperance movement's greatest triumph and, ultimately, its greatest failure. The Eighteenth Amendment to the Constitution banned the manufacture, sale, and transportation of intoxicating liquors, and for a brief period, rates of alcohol consumption and alcohol-related disease did decline. But Prohibition also produced organized crime, widespread lawbreaking, and a cultural backlash against the moralistic framework that had produced it.
The repeal of Prohibition in 1933 did not resolve the underlying problem of alcoholism — it simply removed the legal framework that had been used to address it. The years immediately following repeal saw a renewed search for effective approaches to alcohol use disorder, and it was in this context that Alcoholics Anonymous emerged in 1935. AA's success — and the failure of every previous approach — helped shift the conversation toward the peer support model and, eventually, toward the disease model.
The modern disease model of alcoholism is most closely associated with E. Morton Jellinek, a biostatistician and physiologist who published his landmark work The Disease Concept of Alcoholism in 1960. Jellinek argued that alcoholism was not a single condition but a spectrum of disorders, some of which had the characteristics of a disease: a predictable progression, physical symptoms, and a course that was not primarily determined by the individual's moral choices.
Jellinek's work built on decades of earlier research and advocacy, including the work of Marty Mann, a recovered alcoholic who founded the National Committee for Education on Alcoholism (now the National Council on Alcoholism and Drug Dependence) in 1944. Mann was one of the first women to achieve long-term sobriety in AA, and she became a tireless advocate for the disease model, arguing that alcoholics deserved medical treatment rather than moral condemnation.
The disease model gained institutional support in 1956, when the American Medical Association officially recognized alcoholism as a disease. This recognition had profound practical consequences: it meant that alcoholism could be covered by health insurance, that alcoholics could seek treatment without the stigma of moral failure, and that research funding could be directed toward understanding and treating the condition.
The last four decades have seen an explosion of research on addiction and its treatment. The development of neuroimaging technology has allowed researchers to observe the effects of addiction on the brain in real time, providing biological evidence for the disease model and revealing the specific neural mechanisms through which addiction operates. The discovery of the brain's reward system and the role of dopamine in addiction has transformed our understanding of why people use substances compulsively and why stopping is so difficult.
This research has also produced new treatment approaches. Medication-assisted treatment (MAT) — the use of medications such as methadone, buprenorphine, and naltrexone to reduce cravings and prevent relapse — has been shown in multiple large-scale studies to be highly effective for opioid and alcohol use disorders. Cognitive-behavioral therapy (CBT), motivational interviewing, and contingency management have all been validated as effective psychosocial treatments. The integration of these approaches with peer support models like AA has produced the most effective treatment outcomes yet achieved.
Despite this progress, significant challenges remain. Stigma — the moral framework that dominated thinking about addiction for centuries — has not been eliminated. Many people with addiction disorders still face discrimination in employment, housing, and healthcare. Treatment is not universally accessible; in the United States, only about 10 percent of people who need treatment for a substance use disorder receive it. The opioid epidemic, which has killed hundreds of thousands of Americans since the late 1990s, has exposed the limitations of existing treatment systems and the continuing influence of moral and punitive approaches to addiction.
The history of addiction treatment is a history of slow, uneven progress — of genuine breakthroughs interspersed with setbacks, of scientific advances undermined by social stigma, of individual courage in the face of institutional indifference. Understanding this history is important not only for its own sake, but because it illuminates the present: the treatment approaches we have today, and the barriers that prevent people from accessing them, are both products of this long and complicated history.
Put this into practice with Recovery Compass
Track your sobriety, log daily check-ins, journal your journey, and celebrate every milestone — all private, all on your device.